Aye wa alingbi ti sara si mo wara cancer ti prostate?
Ngu ti zo: Tongana ngu ti zo ayeke gue na li ni, kpale ti cancer ti prostate ayeke kono, na mingi ni a yeke wara ni na popo ti akoli so ngu ti ala ahon 65.
2. Mara ti lo: Akoli so ayeke azo vuko ayeke wara kobela ti cancer ti prostate mingi ahon azo ti amara nde.
3. Azo ti sewa ni: Akoli so kobela ti cancer ti prostate ayeke dä na yâ sewa ti ala, mbilimbili tongana babâ wala ita ti ala ti koli ayeke na kobela ni, ayeke na yâ kota kpale ti wara ni.
4. Aye so aga na lege ti mitele: Ambeni ye so a dü zo na ni na so aga na lege ti mitele, tongana BRCA1 na BRCA2, alingbi ti sala si kobela ti cancer ti prostate amaï.
5 Te kobe alingbi na ni: tengo kobe so asi singo na bengba nyama na so a wara alê ti keke na akugbe ti kasa dä mingi pëpe alingbi ti sala si kobela ti cancer ti prostate amaï.
6. Kota ndowa: Ti kono ahon ndo ni alingbi ti sala si zo awara kobela ti cancer ti prostate, mbilimbili tongana kobela ni ayeke ngangu mingi.
Nyongo manga: Nyongo manga alingbi ti sala si zo awara kobela ti cancer ti prostate, mbilimbili tongana kobela ni ague na li ni mingi wala a yeke gue na zo na kuâ.
8 Nyongo ambeni yorö: Nyongo ambeni yorö tongana ayorö ti futi na akeke nga na ti fâ na asioni pere alingbi ti sala si kobela ti cancer ti prostate amaï.
9. Akobela so aga na lege ti bungbingo koli na wali: Akoli so ayeke na akobela so aga na lege ti bungbingo koli na wali, tongana kobela ti koli na wali wala chlamydia, alingbi ti wara kobela ti cancer ti prostate mingi ahon.
10 Bungbingo koli na wali: Ambeni gingo nda ti ye afa so akoli so ayeke bungbi na awali mingi wala so ayeke bungbi koli na wali mingi ayeke wara kobela ti cancer ti prostate mingi pëpe.
11. Kode ti zingo kamba ti dungo: Akoli so a zi kamba ti dungo ti ala alingbi ti wara kobela ti cancer ti prostate mingi pëpe.
12. Diabète: Akoli so ayeke na kobela ti diabète ayeke na yâ kota kpale ti wara cancer ti prostate, mbilimbili akobela so ayeke ngangu mingi.
A yeke kota ye ti hinga so tongana mbeni koli ayeke na mbeni oko wala mingi ti aye so alingbi ti sara si lo wara cancer ti prostate, a ye pëpe ti tene so lo yeke wara ande ni.
Ye oko, ti hinga aye so alingbi ti sara si kobela ni amû ndo alingbi ti mû maboko na akoli ti mû anzoni desizion na ndo ti gingo nda ti kobela ni nga na ti kangango lege na ni.
Hosseini M, SeyedAlinaghi S, Mahmoudi M, McFarland W: A case-control study of risk factors for prostate cancer in Iran. Acta Med Iran. , 48 (1): 61-6.
Oderda M, Mondino P, Zitella A, Gontero P, Tizzani A: [Update on epidemiology and risk factors of prostate cancer]. Urologia. , 75 (3): 143-8.
Mazdak H, Mazdak M, Jamali L, Keshteli AH: Determination of prostate cancer risk factors in Isfahan, Iran: a case-control study. Med Arh. 2012, 66 (1): 45-8.
Patel AR, Klein EA: Risk factors for prostate cancer. Nat Clin Pract Urol. 2009, 6 (2): 87-95.
Sawada N: Risk and preventive factors for prostate cancer in Japan: The Japan Public Health Center-based prospective (JPHC) study. J Epidemiol. 2017, 27 (1): 2-7.
Mordukhovich I, Reiter PL, Backes DM, Family L, McCullough LE, O'Brien KM, Razzaghi H, Olshan AF: A review of African American-white differences in risk factors for cancer: prostate cancer. Cancer Causes Control. 2011, 22 (3): 341-57.
['Tënë ti ziango kamene na lê: tënë ti seni']
['A zia site so gi ti fa na ye na azo na ti mû wango na ala.']
['A lingbi a sala kusala pëpe na asango so a mû ti hinga wala ti kaï na mbeni kpale ti seni wala kobela, na a lingbi ala so aye ti wara wango ti kaïngo kobela teti ala mveni ahunda mbeni wanganga so ayeke na mbeti ti hinga ye na ndo ni.']
['Bâ so tongana a hunda na zo ti fa wungo ti azo so ayeke na mbeni kobela, a yeke ngangu ti tene lo fa tâ wungo ti azo ni.']
['Gi lakue wango ti wanganga ti mo wala mbeni wanganga so ahinga kua ti lo nzoni na ndo ti kobela ti mo. Zia lâ oko pëpe ti ke wango ti wanganga wala ti ku ti wara ni ndali ti mbeni ye so mo diko na ndo ti site so. Tongana mo bâ so mo yeke na yâ ti mbeni kpale ti seni, iri 911 wala gue hio na hôpital so ayeke nduru na mo.']
['Kengo tene: droit ti lo ti sala tene']
['Ndia ti Amerika na ndo droit ti sigingo na ambeti (Digital Millennium Copyright Act) ti ngu 1998, 17 U.S.C. § 512 (so a hiri ni DMCA) amû lege na azo so ayeke na droit ti sigingo na ambeti ti bâ wala ambeti so asigigi na ndo ti Internet ni adoro droit ti ala so ndia ti Amerika amû na ndo droit ti sigingo na ambeti amû lege na ala ti sala ni. ']
['Tongana mo pensé so mbeni ye so ayeke na ndo ti site ti e wala na yâ ti ambeni ye so e yeke sara andu droit ti mo ti batango ambeti ti e, mo (wala zo so mo sara kua na iri ti lo) alingbi ti tokua na e mbeni mbeti ti hunda ti tene a zi ni wala a kanga lege na mo ti wara ni.']
['A lingbi a tokua ambeti ni na lege ti mbeni lettre so a sû na ndo ti ordinateur wala na lege ti mbeni téléphone (bâ mbage "A-adresse ti téléphone").']
['Ndia ti DMCA ahunda ti tene na yâ ti mbeti ti mo so a tene mbeni zo asara mbeni ye so ake ndia ti droit ti batango ambeti, mo zia atënë so ge: (1) fango peko ti kua so ndia ti batango ambeti ni ake ni; (2) fango peko ti aye so a tene a sara ye ti ke ndia ti batango ambeti ni nga na atënë so alingbi ti mû lege na e ti wara aye ni so; (3) asango ti mo ti wara mo, so andu adresse ti mo, numéro ti téléphone ti mo nga na adresse ti e-mail ti mo; (4) mbeni tënë so mo tene na bê ti mo kue so tënë ti aye ni so mo dema tere dä so ayeke pëpe tënë ti zo so ayeke na droit ti batango ambeti ni, wala zo so ayeke sara kua na iri ti lo, wala ndia ti kodoro ti mo.']
['(5) Mo sû maboko ti mo na gbe ti ngbanga ti mvene na mo tene so atënë so ayeke na yâ ti mbeti ni ayeke tâ tënë nga so mo yeke na ngangu ti sara si a bata droit ti mo ti sigingo na ambeti so a tene a doro ni.']
['Nga (6) mbeni maboko ti zo so ayeke na droit ti sigingo na ambeti ni wala mbeni maboko ti mbeni zo so ayeke sara kua na iri ti zo ni.']
['Tongana mo sû atënë so kue pëpe, a lingbi ti sara si a mû ngoi mingi pëpe ti bâ lege ti tënë ti mo ni.']
['Tënë ti kiri ti bâ zo']
['Tongana mo yeke na mbeni hundango tënë wala mbeni tënë ti tene, tokua ni na e na lege ti mbeni lettre.']
What are the risk factors for prostate cancer?
1. Age: The risk of prostate cancer increases with age, with most cases occurring in men over the age of 65.
2. Race/Ethnicity: African American men have a higher risk of developing prostate cancer than men of other races.
3. Family History: Men with a family history of prostate cancer, particularly a father or brother with the disease, have a higher risk.
4. Genetics: Certain inherited genetic mutations, such as BRCA1 and BRCA2, may increase the risk of prostate cancer.
5. Diet: A diet high in red meat and low in fruits and vegetables may increase the risk of prostate cancer.
6. Obesity: Being overweight or obese may increase the risk of prostate cancer, particularly aggressive forms of the disease.
7. Smoking: Smoking may increase the risk of prostate cancer, particularly advanced or fatal forms of the disease.
8. Chemical Exposure: Exposure to certain chemicals, such as pesticides and herbicides, may increase the risk of prostate cancer.
9. Sexually Transmitted Infections: Men with a history of sexually transmitted infections, such as gonorrhea or chlamydia, may have an increased risk of prostate cancer.
10. Sexual Activity: Some studies suggest that men who have a higher number of sexual partners or engage in frequent sexual activity may have a slightly increased risk of prostate cancer.
11. Vasectomy: Men who have had a vasectomy may have a slightly increased risk of prostate cancer.
12. Diabetes: Men with diabetes may have a higher risk of prostate cancer, particularly aggressive forms of the disease.
It is important to note that having one or more of these risk factors does not necessarily mean that a man will develop prostate cancer, and many men with prostate cancer have no known risk factors.
However, being aware of these risk factors can help men make informed decisions about screening and prevention.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Na ndo ni']
['Na yâ ti BioMedLib, a yeke sala kusala na a-ordinateur so ayeke sala kua gi na ndo ti tele ti ala mveni (na lege ti kode ti mandango ye na lege ti masini) ti leke ahundango tënë na akiringo tënë so a zia na tele ti mba.']
['E to nda ni na ambeti ti senda-ye kutu 35 so ayeke na yâ ti ambeti-sango so a iri ni PubMed/Medline nga na ambeni site ti e so a iri ni RefinedWeb.']